

Pomalidomide Capsules 4 Mg – Generic Pomalyst
$196.00 – $555.00
Pomalidomide Capsules 4 Mg
are FDA-approved oral cancer medications used for the treatment of relapsed or refractory multiple myeloma and Kaposi’s sarcoma. As a third-generation immunomodulatory drug (IMiD), Pomalidomide enhances immune response and directly targets cancer cells. Taken in combination with other agents like dexamethasone, it offers an effective treatment option for patients who have failed previous therapies.
Description
Pomalidomide Capsules 4 Mg
Pomalidomide Capsules 4 Mg are powerful oral medications belonging to the immunomodulatory drug (IMiD) class, used to treat patients suffering from multiple myeloma and Kaposi’s sarcoma, particularly when prior treatment options, such as lenalidomide and bortezomib, have failed.
Pomalidomide is known to regulate the immune system, inhibit angiogenesis, and exert anti-cancer activity. This makes it a valuable choice for patients with difficult-to-treat forms of blood cancer and immune-related sarcoma.
Due to its teratogenic potential, Pomalidomide should be handled with care and prescribed only through a certified REMS (Risk Evaluation and Mitigation Strategy) program.
Indications and Uses
Pomalidomide Capsules 4 Mg are prescribed for the treatment of:
- Multiple Myeloma (relapsed or refractory) in adults who have received at least two prior therapies, including lenalidomide and a proteasome inhibitor.
- Kaposi’s Sarcoma:
- In patients with HIV-associated KS after failure of antiretroviral therapy.
- In HIV-negative patients showing classical Kaposi’s sarcoma.
Pomalidomide is usually administered in combination with low-dose dexamethasone or other cancer medications, as recommended by an oncologist.
Mechanism of Action
Pomalidomide works through multiple immunological and anti-cancer mechanisms:
- Enhances T-cell and natural killer (NK) cell activity to boost the immune system’s ability to attack cancer cells.
- Inhibits angiogenesis, preventing tumors from developing new blood vessels.
- Interrupts cancer cell signaling and growth pathways within the bone marrow niche.
- Suppresses inflammatory cytokines, including TNF-alpha, which are linked to cancer cell survival and proliferation.
This multi-pronged approach provides better outcomes in heavily pretreated patients.
Dosage and Administration
Form: Oral capsule
Strength: 4 mg
Route: Oral
Typical Dose (for multiple myeloma):
- 4 mg capsule once daily on days 1 to 21 of each 28-day cycle, often combined with low-dose dexamethasone.
- The dosage for Kaposi’s sarcoma is individualized depending on the patient’s condition and tolerance.
Administration Instructions:
- Take the capsule at the same time each day.
- Swallow whole with water. Do not break, chew, or open the capsule.
- May be taken with or without food.
- Follow all contraceptive guidelines if you are of childbearing potential, due to the drug’s risk of birth defects.
Benefits of Pomalidomide Capsules 4 Mg
- Effective in patients with previously treated, resistant multiple myeloma
- Oral dosing offers convenience for long-term therapy
- Proven to enhance immune response and disrupt cancer progression
- Demonstrated benefit in Kaposi’s sarcoma with limited treatment options
- Generally well tolerated with regular monitoring
- Backed by global clinical trials and FDA approval
Possible Side Effects
Common side effects:
- Fatigue
- Nausea and vomiting
- Constipation or diarrhea
- Anemia and low white blood cell count
- Skin rash
- Appetite loss
- Muscle cramps
Serious side effects:
- Deep vein thrombosis (blood clots)
- Pulmonary embolism
- Liver dysfunction
- Neutropenia leading to infection
- Tumor lysis syndrome (rare)
- Birth defects in unborn children if taken during pregnancy
Due to hematologic toxicities, frequent blood tests will be required to monitor your white cell and platelet counts.
Precautions and Warnings
Pregnancy Warning:
Pomalidomide is highly teratogenic. It must not be used during pregnancy. Women of reproductive potential must adhere to strict contraceptive measures, and men must also prevent exposure via semen.
Patients must be registered in a REMS program to receive Pomalidomide. Regular pregnancy testing, counseling, and compliance checks are mandatory.
Additional precautions:
- Do not donate blood or sperm during treatment and for a prescribed period after stopping the medication
- Use caution in patients with liver or kidney impairment
- Avoid combining with live vaccines or unapproved antibiotics without medical advice
Drug Interactions
Pomalidomide Capsules 4 Mg can interact with:
- CYP1A2 inhibitors (e.g., fluvoxamine, ciprofloxacin)
- CYP3A4 pathway medications
- Steroids like dexamethasone
- Blood thinners such as warfarin or rivaroxaban
- Immune-suppressing medications
Your doctor should review your entire medication list before starting treatment.
Storage Information
- Store at 20°C to 25°C (68°F to 77°F)
- Keep in original blister packaging
- Protect from heat, moisture, and light
- Keep out of reach of children
- Handle with care; wash hands after handling
Frequently Asked Questions (FAQs)
1. What are Pomalidomide Capsules 4 Mg used for?
They are used to treat relapsed multiple myeloma and Kaposi’s sarcoma in specific patient groups.
2. How is Pomalidomide different from Lenalidomide?
Pomalidomide is a newer-generation IMiD used when patients have already been treated with lenalidomide and become resistant to it.
3. Can I take Pomalidomide during pregnancy?
No. Due to the risk of severe birth defects, it is strictly contraindicated in pregnancy.
4. How long do I need to take Pomalidomide?
Treatment may last several cycles and is based on response and tolerance. Your doctor will determine the exact duration.
5. Is Pomalidomide chemotherapy?
No, it is an immunomodulatory drug, which works differently than chemotherapy but is used to treat cancer.
6. Does it interact with food?
It can be taken with or without food. However, a consistent routine is recommended.
7. What precautions must women take while on this medicine?
Use two reliable forms of contraception and undergo regular pregnancy testing.
8. Can men take Pomalidomide?
Yes, but they must prevent exposure to their partners via semen and must use condoms if their partners are of childbearing potential.
9. Will I need regular monitoring while on this therapy?
Yes. Blood tests, pregnancy tests, and clinical evaluations are necessary at regular intervals.
10. Does Pomalidomide have a generic name?
Yes. Pomalidomide is the generic name. Brand names include Pomalyst.
Reviews
There are no reviews yet.